Table 3 Mean neurite formation defect scores for kinase inhibitors targeting the Aurora and Nuak kinases reveal possible defects in neurite initiation and/or elongation.
Kinase inhibitor targets | Average score | Possible defect |
|---|---|---|
DMSO control | 5.04 | N/A |
Aurora Kinase A | 3.69 | Neurite elongation |
Aurora Kinase B | 1.22 | Neurite initiation |
Aurora Kinase A/B | 1.18 | Neurite initiation |
Aurora Kinase B/C | 3.74 | Neurite elongation |
Aurora Kinase A/B/C | 1.46 | Neurite initiation |
Nuak 1 | 1.09 | Neurite initiation |
Nuak 1/2 | 3.43 | Neurite elongation |